AzTrials
AzTrials

Overweight, ChildhoodLTRNCT04360083

Long-term Assessment of Rhône RéPPOP Care for Overweight and Obese Children.

An observational study of Overweight, Childhood and Pediatric Obesity, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Childhood obesity is a major public health issue since it is a risk factor of adulthood obesity, cardiovascular disease, psychological disorders, and other chronic conditions. RéPPOP is a two year personalized pathway for multidisciplinary care for overweight and obese children, close to patients' homes. Read more about this study

Who is it for?
Ages 13 years and older
Conditions the study is for
Overweight, Childhood, Pediatric Obesity
What is being tested?
Collected data from Rhône RéPPOP database and telephonic questionnaire
How many people
106 participants
Where
1 siteFrance
Study dates
15 Feb 2021to 7 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Overweight and obese children included in RéPPOP care programs between 2007 and 2010

Who may be able to join

  • All overweight and obese children included in RéPPOP care programs from 01/01/07 to 31/12/10

Who cannot join

  • Refusal to respond to the telephonic questionnaire
  • Subjects who withdraw their consent to participate in the study
  • Subjects aged under 12 years

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hospices civils de Lyon, Endocrino-pediatric service

    Bron, 69500

Other trials in France

About this study

Childhood obesity is a major public health issue since it is a risk factor of adulthood obesity, cardiovascular disease, psychological disorders, and other chronic conditions.

RéPPOP is a two year personalized pathway for multidisciplinary care for overweight and obese children, close to patients' homes.

Read more

Short and medium-term assessments of Rhône RéPPOP care for overweight and obese children show encouraging results. Long-term assessment is needed to confirm these results.

The present study aims to assess the long-term efficiency of Rhône RéPPOP care for overweight and obese children by comparing BMI Z-scores at the start and the end of RéPPOP care to the current BMI. This data will be collected through a telephonic questionnaire by the scientific manager.

The study's secondary objectives are to evaluate patients and their families' lifestyle changes and to improve RéPPOP practices.

Being tested
Collected data from Rhône RéPPOP database, telephonic questionnaire
Keywords
Pediatric Obesity, Overweight, Childhood
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Collected data from Rhône RéPPOP databaseOther

    BMI Z-scores at the start and the end of RéPPOP care programs.

  • telephonic questionnaireOther

    Collected data though the telephonic questionnaire : current declared BMI Z-score.

Study groups in NCT04360083
Study groupRoleWhat they receive
Overweight and obese childrenOverweight and obese children included in RéPPOP care programs between 2007 and 2010.
Receives: Other: Collected data from Rhône RéPPOP database; Other: telephonic questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of BMI Z-scores at the start and the end of RéPPOP care programs to the current BMI Z score.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2020
  2. Study start15 Feb 2021
  3. Primary completion7 Dec 2021
  4. Study completion7 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04360083
Sponsor's protocol ID
69HCL19_0285
Other IDs
2020-A00787-32
Acronym
LTR
Status last verified
Mar 2023
First submitted
22 Apr 2020
Last updated
9 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Overweight, Childhood and Pediatric Obesity, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of BMI Z-scores at the start and the end of RéPPOP care programs to the current BMI Z score. (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in